P. Pecchini

Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience

F. Scolari, N. Bossini, F. Valerio, 2020, American Journal of Transplantation.

Vitamin D levels and patient outcome in chronic kidney disease.

C. Zoccali, P. Ravani, F. Mallamaci, 2009, Kidney international.

Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER).

F. Scolari, G. Cancarini, R. Maroldi, 2005, Journal of nephrology.

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.

F. Locatelli, S. Andrulli, L. Del Vecchio, 2013, Journal of nephrology.

Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry.

C. Zoccali, P. Ravani, R. Quinn, 2012, Journal of nephrology.

Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease.

C. Zoccali, P. Ravani, F. Mallamaci, 2008, Kidney international.

When a nephrology ward becomes a COVID-19 ward: the Cremona experience

F. Malberti, P. Pecchini, M. Foramitti, 2020, Journal of Nephrology.

Early Failure Rates of Arterovenous Fistulas for Hemodialysis: Evaluation of Six-Year Activity

D. Marcelli, P. Ravani, F. Malberti, 2001, The journal of vascular access.

Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey

G. Remuzzi, E. Bargagli, P. Rottoli, 2021, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients

C. Zoccali, P. Ravani, R. Quinn, 2013, PloS one.